A phase I/II study of HB-201, an arenavirus-based cancer immunotherapy, alone, or in combination with anti-PD-1 in patients with HPV16+ cancers.

Bharat Burman,Jiaxin Niu,Rom S. Leidner,Ding Wang,Debra L. Richardson,Corinne Iacobucci,Andy Hwang,Xiaoping Qing,Igor Matushansky,Dmitriy Zamarin,Alan Loh Ho,David G. Pfister,Marshall R. Posner

A phase I/II study of HB-201, an arenavirus-based cancer immunotherapy, alone, or in combination with anti-PD-1 in patients with HPV16+ cancers.

2020

Bharat Burman
Jiaxin Niu
Rom S. Leidner
Ding Wang
Debra L. Richardson
Corinne Iacobucci
Andy Hwang
Xiaoping Qing
Igor Matushansky
Dmitriy Zamarin
Alan Loh Ho
David G. Pfister
Marshall R. Posner

TPS3171Background: Human Papillomavirus 16 (HPV16) is linked to several cancer types; treatment options are limited for patients with HPV16+ recurrent or metastatic cancers. The generation and main...

Keywords:

Oncology
anti pd 1
Internal medicine
Cancer immunotherapy
Pathology
Arenavirus
in patient
Medicine
phase i ii

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations